Carolina Ayelen Isnardi (Carolina A Isnardi)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Immune Response

Coronavirus Disease

Top Venues

Clinical rheumatology

Arthritis care & research

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Carolina Ayelen Isnardi, Margarita Landi, Leonel Cruces, Pablo Maid, Claudia Calle Montoro, María A Alfaro, Brian M Roldán, Andrea B Gómez Vara, Pamela Giorgis, Roberto A Ezquer, María G Crespo Rocha, Camila R Reyes Gómez, María Á Correa, Osvaldo L Cerda, Marcos G Rosemffet, Virginia Carrizo Abarza, Santiago Catalan Pellet, Miguel Perandones, Cecilia Reimundes, Yesica Longueira, Gabriela Turk, María F Quiroga, Natalia Laufer, María C De La Vega, Gustavo Citera, Guillermo J Pons-Estel, Emilce E Schneeberger
Humoral and T-cell response to SARS-CoV-2 vaccination in patients with rheumatoid arthritis. Arthritis care & research (2023)
Carolina Ayelen Isnardi, Margarita Landi, Guillermo Javier Pons-Estel, Emilce Edith Schneeberger
COVID19 Vaccine Immunogenicity in Rheumatoid Arthritis: answer to Ranjeet Singh Mahla comment. Arthritis care & research (2023)
Carolina Ayelen Isnardi, Emilce Edith Schneeberger, Jennifer L Kreimer, Paula Carolina Luna, Cristina Echeverría, Karen Roberts, María Celina de la Vega, Belen Maria Virasoro, Margarita Landi, Rosana Maris Quintana, Maria Eugenia D'Angelo Exeni, Nora Kogan, Ingrid Petkovic, Dora Pereira, Maria de Los Ángeles Correa, Marcos David Zelaya, Yohana Soledad Tissera, María Soledad Gálvez Elkin, Cecilia Nora Pisoni, Carla Alonso, Adriana Karina Cogo, Micaela Ana Cosatti, Lucila García, Cinthya Retamozo, María de Los Ángeles Severina, Romina Estefania Nieto, Marcos Rosemffet, Eduardo Mussano, Ana Bertoli, Verónica G Savio, Vanesa Laura Cosentino, Guillermo J Pons-Estel
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data. Clinical rheumatology 41 (10) (2022)
Carolina Ayelen Isnardi, Karen Roberts, Verónica Saurit, Ingrid Petkovic, Roberto Miguel Báez, Rosana Maris Quintana, Yohana Soledad Tissera, Sofía Ornella, Maria Eugenia D'Angelo Exeni, Cecilia Nora Pisoni, Vanessa Viviana Castro Coello, Guillermo Berbotto, María J Haye Salinas, Edson Velozo, Álvaro A Reyes Torres, Romina Tanten, Marcos David Zelaya, Carla Andrea Gobbi, Carla G Alonso, María de Los Ángeles Severina, Florencia Vivero, Alba Paula, Adriana Karina Cogo, Gelsomina Alle, Mariana Pera, Romina Estefania Nieto, Micaela Ana Cosatti, Cecilia Asnal, Dora Pereira, Juan A Albiero, Verónica G Savio, Federico N Maldonado, María Julieta Gamba, Noelia F Germán, Andrea Baños, Josefina Gallino Yanzi, María Soledad Gálvez Elkin, Julieta S Morbiducci, María Victoria Martire, Hernán Maldonado Ficco, Maria Marcela Schmid, Jaime A Villafañe Torres, Maria de Los Ángeles Correa, María Alejandra Medina, María Alejandra Cusa, Julia Scafati, Santiago E Agüero, Nicolás M Lloves Schenone, Enrique Roberto Soriano, Cesar Graf, Bernardo A Pons-Estel, Gimena Gomez, Margarita Landi, María Celina de la Vega, Guillermo J Pons-Estel, null null
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. Clinical rheumatology (2022)
Carolina Ayelen Isnardi, Osvaldo L Cerda, Margarita Landi, Leonel Cruces, Emilce Edith Schneeberger, Claudia Calle Montoro, María Agustina Alfaro, Brian M Roldán, Andrea B Gómez Vara, Pamela Giorgis, Roberto Alejandro Ezquer, María G Crespo Rocha, Camila R Reyes Gómez, Mária de Los Ángeles Correa, Marcos G Rosemffet, Virginia Carrizo Abarza, Santiago Catalan Pellet, Miguel Perandones, Cecilia Reimundes, Yesica Longueira, Gabriela Turk, Maria Florencia Quiroga, Natalia L Laufer, Rosana Maris Quintana, María Celina de la Vega, Nicolás Kreplak, Marina Pifano, Pablo Maid, Guillermo J Pons-Estel, Gustavo Citera
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines. The Journal of rheumatology 49 (12) (2022)